GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Project 3

$441,978
Richard G Vile · Mayo Clinic Rochester · P50 · FY2024 · CA

The Role of the Microenvironment in Barrett's Esophagus

$441,975
Julian Abrams · Columbia University Health Sciences · U54 · FY2022 · CA

Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy

$441,967
Stephen Matthew Hatfield · Northeastern University · R01 · FY2024 · EB

C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS

$441,905
Chi V. Dang · University Of Pennsylvania · R01 · FY2012 · CA

Defining epigenetic signaling to reshape pancreatic tumor microenvironment

$441,899
Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2024 · CA

Identifying the pro-metastatic mechanisms of neutrophil extracellular traps

$441,891
Mikala Egeblad · Johns Hopkins University · R01 · FY2024 · CA

Neural Niche in Promoting Brain Metastatic Tumor Progression

$441,889
Siyuan Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA

Metabolic Barriers to T Cell Activation in Clear Cell Renal Cell Carcinoma

$441,879
Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2020 · CA

Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesis

$441,873
Mark A Atkinson · University Of Florida · R01 · FY2020 · DK

Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs

$441,751
Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA

Overcoming primary and secondary resistance in wild-type BRAF melanoma

$441,736
Andrew E Aplin · Wistar Institute · P01 · FY2023 · CA

Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome

$441,722
Robert C Seeger · Children'S Hospital Of Los Angeles · R33 · FY2010 · CA

Regulation of Tumor Immunogenicity in Glioblastoma

$441,658
Sze Chun Winson Ho · University Of California, San Francisco · R01 · FY2024 · NS

Lymphoid residency of Tcf-1+ CD8+ T cells during tumor vaccine responses

$441,601
Nu Zhang · University Of Texas Hlth Science Center · R01 · FY2024 · AI

Pancreatic Cancer Cell Mechanics and Imaging

$441,510
Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2014 · CA

Regulation of tumor-infiltrating T cells by macrophages

$441,506
Xiaopei Huang · Ohio State University · R01 · FY2025 · CA

Targeting NQO1+ tumor to trigger innate and adaptive immunity

$441,498
Xiumei Huang · Indiana University Indianapolis · R01 · FY2023 · CA

MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1

$441,496
Pawel Kalinski · Roswell Park Cancer Institute Corp · P50 · FY2014 · CA

Eph Receptor Targeting Strategies

$441,467
Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2011 · CA

HSC transduction in situ by cellular delivery of integrating viral vectors

$441,464
Peter Kurre · Oregon Health & Science University · R01 · FY2012 · HL

TGF-Beta Suppression and Promotion of Mammary Carcinomas

$441,398
Harold L Moses · Vanderbilt University · R01 · FY2008 · CA

Tumor-stromal interactions as targets of tumor metastasis suppressors

$441,361
Marsha R Rosner · University Of Chicago · R01 · FY2015 · CA

NextGen RNAi Delivery to Breast Tumors for Selective mTORC2 Blockade

$441,312
Craig Lewis Duvall · Vanderbilt University · R01 · FY2022 · CA

Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity

$441,308
Viswanathan Palanisamy · University Of New Mexico Health Scis Ctr · R01 · FY2024 · DE

Overcoming ibrutinib resistance in mantle cell lymphoma

$441,302
Alexey V. Danilov · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA